Fahong Wu

Mr. Fahong Wu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
HDHongyang Deng
Hongyang Deng
JZJiaxing Zhang
Jiaxing Zhang
FWFahong Wu
Fahong Wu
FWFengxian Wei
Fengxian Wei
WHWei Han
Wei Han
YZYoucheng Zhang
Youcheng Zhang
The lymphatic system is a channel for fluid transport and cell migration, but it has always been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has long been recognized as a major molecular driver of lymphangiogenesis. However, many studies have shown that the neural network of lymphatic signaling is complex. Lymphatic vessels have been found to play an essential role in the immune regulation of tumor metastasis and cardiac repair. This review describes the effects of lipid metabolism, extracellular vesicles, and flow shear forces on lymphangiogenesis. Moreover, the pro-tumor immune tolerance function of lymphatic vessels is discussed, and the tasks of meningeal lymphatic vessels and cardiac lymphatic vessels in diseases are further discussed. Finally, the value of conversion therapy targeting the lymphatic system is introduced from the perspective of immunotherapy and pro-lymphatic biomaterials for lymphangiogenesis.

1 August 2022 in Cell Cycle
Verified
Journal Article
Closed access
FWFahong Wu
Fahong Wu
YMYudong Mao
Yudong Mao
TMTao Ma
Tao Ma
XWXiaoli Wang
Xiaoli Wang
HWHangzhi Wei
Hangzhi Wei
YZYoucheng Zhang
Youcheng Zhang
Colorectal cancer (CRC) is now the third most prevalent tumor and one of the deadliest cancers worldwide, with an increasing prevalence every year. Therefore, we urgently need to understand the mechanisms regulating the progression of colorectal cancer and find potential diagnostic biomarkers. In this study, we performed an analysis using the TCGA and GEO databases to find a molecular biomarker for the diagnosis of CRC, namely CTPS1. The results of this analysis revealed that CTPS1 could promote tumor proliferation and metastasis. Furthermore, bioinformatics analysis revealed that CTPS1 promoted CRC progression through cell cycle and p53 pathways. Further investigation demonstrated that CTPS1 might be involved in the regulation of CCNB1, RRM2, GTSE1, CDK2 and CHEK2 genes. Moreover, PCR confirmed that CTPS1 regulated GTSE1 and CDK2 molecules. Then, western blot was used to verify that CTPS1 promoted the expression of GTSE1 and CDK2 by inhibiting the expression of p53. In summary, we identified an important diagnostic biomarker for CRC, namely CTPS1, and its importance was validated at the cellular level. These results suggest that CTPS1 could serve as a candidate biomarker for CRC and CTPS1 inhibitors may be a potential treatment for CRC.

10 February 2023 in Immunological Investigations
Verified
Journal Article
Closed access
HWHangzhi Wei
Hangzhi Wei
YMYudong Mao
Yudong Mao
HZHuihan Zhang
Huihan Zhang
FWFahong Wu
Fahong Wu
YZYoucheng Zhang
Youcheng Zhang
Programmed death ligand 1 (PD-L1) is expressed in hepatocellular carcinoma (HCC) cells. PD-L1 function and structure are regulated through glycosylation and various signaling pathways. However, the...


22 June 2026 in Angiology
Verified
Journal Article
Closed access
FWFahong Wu
Fahong Wu
XHXiaojin Huang
Xiaojin Huang